16:07 EDT Dynavax raises 2023 Heplisav-B revenue to $210M-$220M from $200M-$215M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DVAX:
